Zhejiang Huahai Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is DULOXETINE HYDROCHLORIDE, USP, with a corresponding US DMF Number 23051.
Remarkably, this DMF maintains an Active status since its submission on March 05, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 05, 2013, and payment made on November 23, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II